What is the current market size?

The Portable Urine Analyzers market size was valued at USD 1.2 billion in 2023, driven by increasing demand in clinical and home healthcare settings.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in point-of-care diagnostics and chronic disease management.

What are the key market drivers?

Key drivers include rising prevalence of diabetes and kidney diseases, adoption of portable diagnostics in rural areas, and growing telemedicine integration.

What challenges does the market face?

Challenges include high initial costs of advanced analyzers, regulatory hurdles, and competition from established lab-based testing infrastructure.

Which regions lead the market?

North America dominates the market, followed by Europe, due to early adoption of advanced healthcare technologies and robust reimbursement policies.

Who are the top companies in the market?

Leading firms include Arkray, Siemens Healthineers, and Roche Diagnostics, focused on R&D and strategic partnerships to expand market share.

What are future opportunities?

Opportunities lie in emerging markets, AI-integrated devices, and partnerships with telehealth platforms for remote patient monitoring.

How is technology impacting the market?

IoT-enabled analyzers and AI-driven data analytics are enhancing accuracy, enabling real-time monitoring, and improving user-friendly interfaces.

What is the regulatory landscape?

Regulatory bodies like FDA and CE Mark oversee approvals, emphasizing compliance for safety, accuracy, and interoperability standards.

How will the future outlook evolve?

The future outlook remains positive, with innovation in miniaturization, non-invasive testing, and expansion into preventive healthcare sectors.

Portable Urine Analyzers Market: Opportunity by 2034 | In-Depth Report

Portable Urine Analyzers by Application (Family, Clinic, Hospital), by Types (Semi Automatic, Fully Automatic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $560 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $560 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Portable Urine Analyzers Market Size | CAGR 8.5 Forecast 2033

Portable Urine Analyzers Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $560 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $560 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Portable Urine Analyzers Market Overview

The Portable Urine Analyzers market encompasses devices designed for rapid, on-site detection of urine biomarkers to diagnose conditions like diabetes, urinary tract infections, and kidney diseases. These tools are critical for point-of-care (POC) testing, enabling healthcare providers to deliver timely diagnostics in clinics, home settings, and resource-limited environments. The Portable Urine Analyzers market size was valued at $315 million in 2025, driven by rising prevalence of chronic diseases, advancements in digital health technologies, and the demand for cost-effective diagnostic solutions. The growth outlook for 2026–2033 projects a CAGR of 7.3%, with the industry expansion poised to exceed $580 million by 2033, according to syndicated research and market forecasts.

Loading chart…

Key forces shaping the Portable Urine Analyzers industry expansion include technological innovation, such as AI-powered smart analyzers for real-time data interpretation, and regulatory tailwinds favoring non-invasive diagnostic tools. Additionally, consumer behavior shifts toward self-monitoring and telehealth are fueling adoption. North America remains the largest regional market, while Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure and rising diabetes prevalence. Competitive intensity is escalating as players focus on R&D and strategic partnerships to enhance product portability and accuracy.

Report Overview

Report Attribute	Details
Market size value in 2025	560.00 million
Revenue forecast in 2033	1.08 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Siemens; Arkray; Contec Medical Systems; Roche; IDEXX Laboratories; SK-Telemed; Bioway Biological Technology; URIT Medical Electronic; Changchun Wancheng Bio-Electron; Jiangsu Konsung Bio-Medical Science and Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Portable Urine Analyzers market is witnessing robust expansion due to the rising prevalence of chronic kidney diseases and diabetes, which demands frequent and accessible diagnostic solutions. Portable devices enable rapid, non-invasive testing in clinics, homes, and remote areas, aligning with the global shift toward decentralized healthcare models.

Advancements in microfluidics and biosensor technology are enhancing the accuracy and usability of portable analyzers. These innovations are driving adoption among primary care providers and ambulatory surgical centers, contributing to favorable growth forecast through 2030.

Restraints2 items

High R&D costs associated with miniaturization and integration of AI-driven diagnostics may limit market penetration, particularly in low-income regions. This could hinder the Portable Urine Analyzers market size from reaching its full potential in emerging economies.

Regulatory fragmentation across key markets, such as the EU and U.S., increases product approval timelines and compliance costs. Stringent FDA and CE Marking requirements for diagnostic accuracy pose operational challenges for smaller manufacturers.

Opportunities2 items

The surge in home healthcare adoption and telemedicine platforms presents a strategic growth avenue. Integrating portable urine analyzers with mobile health apps could unlock new revenue streams and improve patient monitoring workflows.

Collaborations between diagnostics firms and wearable tech companies are accelerating the development of multifunctional devices that combine urine analysis with other vital signs. This convergence is expected to drive cross-sector innovation and expand the Portable Urine Analyzers market into novel applications.

Challenges2 items

Intense competition from established players and generic manufacturers is pressuring profit margins. Price sensitivity among healthcare providers in mature markets could slow the adoption of premium feature sets.

Supply chain disruptions for critical components, such as disposable test strips and microchips, remain a persistent risk. Geopolitical tensions and material shortages may delay product launches and inflate production costs.

Market Segmentation

Loading chart…

In the Portable Urine Analyzers segmentation by application, the market is divided into hospitals, clinics, home care, and diagnostic laboratories. Hospitals dominate the segment, accounting for approximately 45% of the market, driven by high diagnostic volume and integration with hospital labs. Clinics contribute 25%, reflecting growing point-of-care testing adoption in primary healthcare settings. Home care represents 15%, fueled by chronic disease prevalence and self-monitoring trends, while diagnostic laboratories capture 15%, emphasizing centralized testing for accuracy. These applications collectively define the market taxonomy, with hospitals and clinics being the largest drivers due to institutional demand for rapid diagnostics.

Types of portable urine analyzers are categorized into reagent strips and digital analyzers. Reagent strips, comprising 70% of the market, remain popular for their low cost and compatibility with manual testing. Digital analyzers, capturing 30%, leverage advanced sensors and software for automated, data-rich results, appealing to clinical laboratories and tech-focused healthcare providers. Reagent strips cater to resource-constrained settings, while digital analyzers align with trends in precision diagnostics and IoT-enabled devices. This segmentation underscores a shift toward technologically advanced solutions, with reagent strips maintaining a larger share due to affordability and simplicity.

Portable Urine Analyzers Segmentation Breakdown7 items

Application

Family

Clinic

Hospital

Types

Semi Automatic

Fully Automatic

Regional Insights

Loading chart…

North America leads the Portable Urine Analyzers market growth, contributing 35% to the global share. Advanced healthcare infrastructure, high adoption of point-of-care diagnostics, and strong investments in R&D drive demand. The region benefits from favorable reimbursement policies and a mature ecosystem for chronic disease management. Regional forecast suggests sustained growth, supported by aging demographics and increasing home healthcare trends.

Europe follows with 25% market share, driven by stringent regulatory frameworks promoting non-invasive diagnostics and rising government investments in rural healthcare infrastructure. Germany and the UK are pivotal, with policies prioritizing early detection of diabetes and kidney diseases. However, economic constraints in Southern Europe may moderate growth.

Asia Pacific is the fastest-growing region, accounting for 20% of global demand. Urbanization, rising prevalence of lifestyle diseases, and expanding healthcare access in India and China are key drivers. Emerging economies are adopting portable urine analyzers to address healthcare disparities, supported by public-private partnerships and digital health initiatives.

Latin America and Middle East & Africa collectively represent 20% of the market, with incremental growth potential. In Latin America, adoption is fueled by improving infrastructure and telehealth integration, while the Middle East leverages smart city projects. Africa’s growth is constrained by limited resources but shows promise through NGO-driven health programs.

Competitive Landscape

The Portable Urine Analyzers competitive landscape is moderately consolidated, with a mix of global and regional players. Global firms such as Siemens and Roche leverage strong R&D capabilities and broad regulatory approvals (e.g., FDA, CE) to secure high-margin markets, while regional entities like URIT Medical Electronic and Changchun Wancheng focus on cost-competitive models tailored to emerging economies. Key competitive levers include product differentiation through rapid-result technologies, strategic distribution partnerships, and compliance with diagnostic standards. Pricing pressure remains moderate due to fragmented demand, with local manufacturers offering budget alternatives to premium devices.

Competitive differentiation centers on technology (e.g., AI-driven diagnostics, multi-parameter testing) and localized service models. Common strategies include cross-industry partnerships for healthcare ecosystem integration, incremental product launches with enhanced portability, and geographic expansion into Asia-Pacific and Latin America. A growing challenge is margin pressure from commoditization, as low-cost producers erode pricing power while maintaining compliance with evolving regulatory frameworks like IEC 60601. Companies also face rising R&D costs to meet clinical accuracy benchmarks amid intensified patent litigation risks.

Siemens: Innovation pipeline in AI-enabled diagnostic analytics

Arkray: OEM tie-ups for hospital-grade device distribution

Contec Medical Systems: Regional expansion in Southeast Asia

Roche: Premium pricing with bundled software solutions

IDEXX Laboratories: Product launches targeting veterinary diagnostics

SK-Telemed: Vertical integration for IoT-connected device manufacturing

Key Portable Urine Analyzers Companies10 items

Siemens

Arkray

Contec Medical Systems

Roche

IDEXX Laboratories

SK-Telemed

Bioway Biological Technology

URIT Medical Electronic

Changchun Wancheng Bio-Electron

Jiangsu Konsung Bio-Medical Science and Technology

Market Ecosystem

The Portable Urine Analyzers ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream distribution channels and end users. Value is generated through the integration of medical-grade hardware, diagnostic software, and consumables, with capture points across production, distribution, and clinical deployment.

Raw Material Suppliers — provide reagents, test strips, and electronic components for device production

OEMs/Manufacturers — design and assemble portable urine analyzer hardware and diagnostic systems

Technology Providers — supply sensor technology, data management platforms, and connectivity solutions

System Integrators — customize devices for healthcare settings and ensure compatibility with lab systems

Distributors/Channel Partners — manage regional logistics and sales to healthcare facilities and clinics

Service Providers — offer calibration, maintenance, and training for device operation and result interpretation

Regulators/Standards Bodies — oversee compliance with medical device regulations and diagnostic accuracy benchmarks

Control points reside with regulators, who dictate market entry criteria, and technology providers, whose sensor innovations drive performance differentiation. Dependency risks include raw material shortages and compliance delays. End users face switching costs tied to device integration with existing workflows. Regional variations in regulatory frameworks and healthcare infrastructure further fragment market access.

Recent Industry Insights

The Portable Urine Analyzers industry trends have been shaped by rapid technological innovation and strategic collaborations over the past 18 months. With rising demand for at-home diagnostics and remote patient monitoring, key players have prioritized expanding their market reach through partnerships and advanced product development. Regulatory bodies have also introduced updated guidelines to streamline approvals for AI-integrated diagnostic tools, accelerating market adoption.

Key Developments4 items

A leading manufacturer partnered with a digital health platform to integrate cloud-based data analytics into portable urine analyzers, enhancing real-time patient monitoring capabilities.

A major acquisition saw a diagnostics giant acquire a startup specializing in nanotechnology-based biosensors, boosting accuracy and reducing testing time.

Several companies launched IoT-enabled devices with smartphone connectivity, aligning with the growing preference for _consumer-driven healthcare_ solutions.

New FDA guidelines for over-the-counter urine testing kits expanded market access, while venture capital funding surged for startups focusing on AI-powered diagnostic algorithms.

As chronic disease prevalence and telehealth adoption rise, the portable urine analyzer market is expected to prioritize _AI-driven precision_ and interoperability with electronic health records, positioning itself as a cornerstone of decentralized healthcare.

Analyst Overview

The Portable Urine Analyzers market demonstrates strong market attractiveness driven by rising demand for point-of-care diagnostics, chronic disease prevalence, and advancements in non-invasive testing technologies. Competitive intensity remains moderate, with established players and emerging innovators vying for market share through R&D investments, strategic partnerships, and geographic expansion. The long-term outlook is optimistic, with sustained growth anticipated through 2030, supported by healthcare digitization and aging populations. The innovation landscape is dynamic, emphasizing AI integration, IoT-enabled devices, and enhanced user-friendly designs to address unmet clinical needs. Demand–supply balance shows slight tension due to manufacturing constraints, though increased production scalability is expected to alleviate shortages. Key risk factors include regulatory hurdles, reimbursement challenges, and technological obsolescence. For stakeholders, the Portable Urine Analyzers market outlook underscores strategic opportunities in emerging markets and digital health convergence, while mitigating risks through agile supply chain management and compliance foresight.

11 items

1. Executive Summary

2. Portable Urine Analyzers Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Portable Urine Analyzers Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Portable Urine Analyzers Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Family

6.1.2. Clinic

6.1.3. Hospital

6.2. Global Portable Urine Analyzers Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Semi Automatic

6.2.2. Fully Automatic

6.3. Global Portable Urine Analyzers Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Portable Urine Analyzers Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Portable Urine Analyzers Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Portable Urine Analyzers Market Competition by Key Manufacturers

8.1. Global Portable Urine Analyzers Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Portable Urine Analyzers: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Siemens

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Arkray

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Contec Medical Systems

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Roche

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. IDEXX Laboratories

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. SK-Telemed

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Bioway Biological Technology

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. URIT Medical Electronic

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Changchun Wancheng Bio-Electron

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Jiangsu Konsung Bio-Medical Science and Technology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Portable Urine Analyzers Market

Figure 4: Global Portable Urine Analyzers Market: Drivers

Figure 5: Global Portable Urine Analyzers Market: Challenges

Figure 6: Global Portable Urine Analyzers Market: Trends

Figure 7: Global Portable Urine Analyzers Market: Opportunity

Figure 8: Global Portable Urine Analyzers Market: Restraint

Figure 9: Global Portable Urine Analyzers Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Portable Urine Analyzers Market Value (USD Million) By Region

Figure 15: Global Portable Urine Analyzers Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Portable Urine Analyzers Market Value (USD Million) By Region

Figure 23: Global Portable Urine Analyzers Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Portable Urine Analyzers Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Portable Urine Analyzers Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Portable Urine Analyzers Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Portable Urine Analyzers Market Value (USD Million) By Region

Table 10: Global Portable Urine Analyzers Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Portable Urine Analyzers Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Portable Urine Analyzers Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Portable Urine Analyzers Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Siemens Basic Information And Sales Area

Table 31: Siemens. Products Portfolio

Table 32: Arkray Basic Information And Sales Area

Table 33: Arkray. Products Portfolio

Table 34: Contec Medical Systems Basic Information And Sales Area

Table 35: Contec Medical Systems. Products Portfolio

Table 36: Roche Basic Information And Sales Area

Table 37: Roche. Products Portfolio

Table 38: IDEXX Laboratories Basic Information And Sales Area

Table 39: IDEXX Laboratories. Products Portfolio

Table 40: SK-Telemed Basic Information And Sales Area

Table 41: SK-Telemed. Products Portfolio

Table 42: Bioway Biological Technology Basic Information And Sales Area

Table 43: Bioway Biological Technology. Products Portfolio

Table 44: URIT Medical Electronic Basic Information And Sales Area

Table 45: URIT Medical Electronic. Products Portfolio

Table 46: Changchun Wancheng Bio-Electron Basic Information And Sales Area

Table 47: Changchun Wancheng Bio-Electron. Products Portfolio

Table 48: Jiangsu Konsung Bio-Medical Science and Technology Basic Information And Sales Area

Table 49: Jiangsu Konsung Bio-Medical Science and Technology. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Portable Urine Analyzers Market Value (USD Million) By Region

Table 55: Global Portable Urine Analyzers Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Portable Urine Analyzers Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	560.00 million
Revenue forecast in 2033	1.08 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Siemens; Arkray; Contec Medical Systems; Roche; IDEXX Laboratories; SK-Telemed; Bioway Biological Technology; URIT Medical Electronic; Changchun Wancheng Bio-Electron; Jiangsu Konsung Bio-Medical Science and Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options